We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$622M
AUM Growth
-$1.43M
Cap. Flow
+$9.58M
Cap. Flow %
1.54%
Top 10 Hldgs %
59.95%
Holding
37
New
4
Increased
15
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$19.2M
2
HUM icon
Humana
HUM
+$17M
3
BRKR icon
Bruker
BRKR
+$9.4M
4
ELV icon
Elevance Health
ELV
+$9.31M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.52M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.93M
2
GILD icon
Gilead Sciences
GILD
+$8.79M
3
BIIB icon
Biogen
BIIB
+$8.1M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$7.22M
5
CVS icon
CVS Health
CVS
+$6.62M

Sector Composition

Rank Sector Weight
1 Healthcare 99.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$61.3M 9.85%
1,351,722
-6,748
-0.5% -$314K
ABT icon
2
Abbott
ABT
$175B
$57.8M 9.29%
687,260
-76,416
-10% -$6.02M
BSX icon
3
Boston Scientific
BSX
$65.4B
$47.6M 7.66%
1,108,336
-6,838
-0.6% -$263K
BAX icon
4
Baxter International
BAX
$11.7B
$37.9M 6.09%
462,305
+14,077
+3% +$1.09M
GILD icon
5
Gilead Sciences
GILD
$167B
$30.1M 4.83%
445,056
-133,681
-23% -$8.79M
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
$29.2M 4.7%
499,354
-39,271
-7% -$2.32M
RVTY icon
7
Revvity
RVTY
$12.3B
$28.9M 4.65%
300,198
-42,883
-12% -$3.99M
BIIB icon
8
Biogen
BIIB
$30.4B
$26.9M 4.33%
115,126
-35,074
-23% -$8.1M
INCY icon
9
Incyte
INCY
$23.4B
$26.7M 4.29%
313,893
+52,600
+20% +$4.22M
BIO icon
10
Bio-Rad Laboratories Class A
BIO
$8.15B
$26.6M 4.27%
85,026
-2,371
-3% -$710K
A icon
11
Agilent Technologies
A
$37.1B
$21.6M 3.47%
289,065
+8,714
+3% +$646K
ELV icon
12
Elevance Health
ELV
$80.9B
$20.6M 3.32%
73,107
+34,094
+87% +$9.31M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$70.9B
$18M 2.9%
+57,635
New +$19.2M
HUM icon
14
Humana
HUM
$48B
$17.7M 2.85%
+66,900
New +$17M
QGEN icon
15
Qiagen
QGEN
$8.49B
$17.2M 2.76%
399,385
+25,001
+7% +$1.04M
TAK icon
16
Takeda Pharmaceutical
TAK
$54.8B
$14.1M 2.27%
796,299
+148,848
+23% +$2.71M
PRGO icon
17
Perrigo
PRGO
$1.48B
$13.2M 2.13%
277,844
-30,176
-10% -$1.44M
BRKR icon
18
Bruker
BRKR
$8.86B
$11.1M 1.79%
+223,004
New +$9.4M
PDCO
19
DELISTED
Patterson Companies, Inc.
PDCO
$10.7M 1.73%
469,255
+18,892
+4% +$420K
PTCT icon
20
PTC Therapeutics
PTCT
$6.52B
$10.3M 1.66%
229,498
+34,755
+18% +$1.37M
VTRS icon
21
Viatris
VTRS
$20.1B
$9.61M 1.54%
504,592
-286,108
-36% -$6.33M
CVS icon
22
CVS Health
CVS
$137B
$9.58M 1.54%
175,743
-122,990
-41% -$6.62M
CAH icon
23
Cardinal Health
CAH
$53.5B
$9.29M 1.49%
197,299
+34,664
+21% +$1.6M
IONS icon
24
Ionis Pharmaceuticals
IONS
$8.99B
$8.45M 1.36%
131,514
-102,200
-44% -$7.22M
UHS icon
25
Universal Health Services
UHS
$9.15B
$8.44M 1.36%
64,742
+1,836
+3% +$231K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2019 Portfolio in Review

As of Q2 2019, Sector Gamma AS held 37 positions worth $622M, down 0.23% from $624M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q2 2019 filing shows 4 new, 15 increased, 15 reduced and 3 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 57,635 shares worth $18M. The largest sale was Merck, an estimated $9.93M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q2 2019 buy was Regeneron Pharmaceuticals: 57,635 shares worth $18M.
  • Sector Gamma AS added most to Elevance Health in Q2 2019, an estimated $9.31M increase.
  • Sector Gamma AS's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $8.79M.
  • Sector Gamma AS fully exited Merck in Q2 2019, selling an estimated $9.93M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $622M portfolio in Q2 2019.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q2 2019.
  • Sector Gamma AS's portfolio value fell 0.23% quarter-over-quarter to $622M.

Based on Sector Gamma AS's 13F filing for Q2 2019, filed 31 Jul 2019.